Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer
- 30 November 2006
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 42 (17), 3057-3064
- https://doi.org/10.1016/j.ejca.2006.05.039
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice GuidelineJournal of Clinical Oncology, 2005
- Mechanisms of Disease: defensins in gastrointestinal diseasesNature Clinical Practice Gastroenterology & Hepatology, 2005
- Discovery and Identification of α-Defensins as Low Abundant, Tumor-Derived Serum Markers in Colorectal CancerGastroenterology, 2005
- Identification of Defensin α6 as a Potential Biomarker in Colon AdenocarcinomaPublished by Elsevier BV ,2005
- Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker studyBMC Cancer, 2005
- α-Defensins in the gastrointestinal tractMolecular Immunology, 2003
- Defensins: antimicrobial peptides of innate immunityNature Reviews Immunology, 2003
- Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelinesEuropean Journal Of Cancer, 2003
- Colorectal Cancer ScreeningPublished by American Medical Association (AMA) ,2003
- The case for population-based screening for colorectal cancerNature Reviews Cancer, 2002